News

Filter

Current filters:

Enablex

1 to 9 of 32 results

Watson seeking to market generic Enablex in USA; Novartis files patent infringement suit

30-04-2009

USA-based Watson has asked the Food and Drug Administration to approve a generic version of Swiss drug…

Darifenacin Extended-Release TabletsEnablexNovartis

P&G looking to sell pharma operations

16-02-2009

USA-based Procter & Gamble, the world's largest consumer products group, which also has a significant…

ActonelAventis PharmaDarifenacin Extended-Release TabletsEnablexOmeprazolePrilosecProcter & GambleRisedronate SodiumSanofi-Aventis

Beijing Med-Pharm to market Enablex in China

03-12-2007

Beijing Med-Pharm, one of China's leading pharmaceutical companies, and Shanghai Novartis Trading,…

Darifenacin Extended-Release TabletsEnablexNovartis

Ardana's fiscal 2007 loss per share widens 28.6%

09-07-2007

Scottish drugmaker Ardana says that total revenues from product sales for the year ended March 31, 2007,…

Darifenacin Extended-Release TabletsEnablexStriantTestodermTestosterone

Ardana/Novartis commence marketing Emselex in UK

27-11-2006

Edinburgh, Scotland-based Ardana has commenced UK marketing of Emselex/Enablex (darifenacin), a novel…

Darifenacin Extended-Release TabletsEnablexNovartis

Novartis to develop Enablex in USA with P&G

18-07-2005

Swiss drug major Novartis and the pharmaceutical division of the USA's Procter & Gamble have entered…

Darifenacin Extended-Release TabletsEnablexNovartisProcter & Gamble

Emselex increases dry days for OAB patients

28-03-2005

New data presented at the European Association of Urology congress in Istanbul, Turkey, show that Novartis'…

Darifenacin Extended-Release TabletsEnablexNovartisSheffield

1 to 9 of 32 results

COMPANY SPOTLIGHT

Menarini

Back to top